No image

ipsogen® JAK2 RGQ PCR Kit

Details

Device typeJAK2 V617F gene mutation IVD, kit, nucleic acid technique (NAT): A collection of reagents or other associated materials intended to be used to detect or monitor the V617F mutation in the Janus kinase 2 (JAK2) gene in a clinical specimen, using a nucleic acid technique (NAT). This mutation is associated with haematological abnormalities that may include essential thrombocythemia, polycythemia vera, primary myelofibrosis or leukaemia.

FDA categoryJak2 Gene Mutation Detection Test

Device ID04053228015444

Catalog number673633

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
cobas® EGFR Mutation Test v2Roche Molecular Systems, Inc.Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	2.0	Roche Molecular Systems, Inc.	Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
Xpert BCR-ABL UltraCepheidPhiladelphia chromosome/BCR-ABL mRNA expression IVD, kit, nucleic acid technique (NAT)	GXBCRABL-US-10	Cepheid	Philadelphia chromosome/BCR-ABL mRNA expression IVD, kit, nucleic acid technique (NAT)
PGDx elio™ serverPersonal Genome Diagnostics Inc.Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	B-01-20800	Personal Genome Diagnostics Inc.	Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
oncoReveal CDx Box 3Pillar Biosciences, Inc.Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)	HDA-LC-2001-48-3	Pillar Biosciences, Inc.	Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)